福森药业(01652):中正天恒获委任为新任核数师

智通财经
Dec 24, 2025

智通财经APP讯,福森药业(01652)发布公告,由于董事会与毕马威会计师事务所(毕马威)未能就本集团截至2025年12月31日止财政年度综合财务报表的建议审核费用达成共识,故毕马威已辞任本公司核数师,自2025年12月24日起生效。

在审核委员会的建议下,中正天恒会计师有限公司(中正天恒)获委任为本公司新任核数师,以填补毕马威离任后的临时空缺,自2025年12月24日起生效,任期至本公司下届股东周年大会结束为止。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10